Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes

Conclusion:
Both serum chemerin and hs-CRP could be considered as markers of subclinical atherosclerosis, and hence, may be utilized for the early detection of macrovascular disease, in Egyptian patients with type 2 diabetes.

Source: Therapeutic Advances in Endocrinology and Metabolism - March 30, 2016 Category: Endocrinology Authors: Lachine, N. A., Elnekiedy, A. A., Megallaa, M. H., Khalil, G. I., Sadaka, M. A., Rohoma, K. H., Kassab, H. S. Tags: Original Research Source Type: research